PuraStat as secondary therapy for hemostasis in Mallory−Weiss syndrome with oral antithrombotic medication
2024

Using PuraStat for Bleeding in Mallory-Weiss Syndrome

publication Evidence: low

Author Information

Author(s): Higashino Makoto, Murakami Hidehiro, Hirata Tetsu, Miyaoka Hiroaki

Primary Institution: Saiseikai Matsuyama Hospital

Hypothesis

Can PuraStat be effective for achieving hemostasis in Mallory-Weiss syndrome when other methods fail?

Conclusion

PuraStat can achieve complete hemostasis in Mallory-Weiss syndrome when traditional methods are insufficient.

Supporting Evidence

  • PuraStat has been used successfully in other types of gastrointestinal bleeding.
  • The patient achieved hemostasis after PuraStat was applied.
  • This is the first report of PuraStat being used for Mallory-Weiss syndrome.

Takeaway

If someone is bleeding in their stomach because of vomiting, PuraStat can help stop the bleeding when other treatments don't work.

Methodology

The patient was treated with endoscopy and PuraStat was applied to the bleeding site after other methods failed.

Limitations

This is a single case report, so broader conclusions cannot be drawn.

Participant Demographics

67-year-old man with a history of coronary artery bypass grafting and on antithrombotic medication.

Digital Object Identifier (DOI)

10.1002/deo2.70033

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication